Advertisement
Research paper| Volume 33, P48-58, March 2018

Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype

  • Frank R. Wendt
    Correspondence
    Corresponding author at: Center for Human Identification, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., CBH-250, Fort Worth, TX 76107, USA.
    Affiliations
    Center for Human Identification, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107, USA

    Graduate School of Biomedical Sciences, 3500 Camp Bowie Blvd., Fort Worth, TX 76107, USA
    Search for articles by this author
  • Antti Sajantila
    Affiliations
    Department of Forensic Medicine, University of Helsinki, P.O. Box 40, 00014 Helsinki, Finland
    Search for articles by this author
  • Bruce Budowle
    Affiliations
    Center for Human Identification, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107, USA

    Graduate School of Biomedical Sciences, 3500 Camp Bowie Blvd., Fort Worth, TX 76107, USA

    Center of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah, Saudi Arabia
    Search for articles by this author
Published:November 25, 2017DOI:https://doi.org/10.1016/j.fsigen.2017.11.012

      Highlights

      • Full-gene haplotypes are described for trans-acting tramadol metabolism genes UGT2B7, ABCB1, OPRM1, and COMT.
      • Population genetic summary statistics are reported for 2,504 1000 Genomes Project individuals.
      • Intergenic analyses indicate moderate association between diplotype information at CYP2D6, UGT2B7, ABCB1, OPRM1, and COMT.
      • There is little association between predicted activity of trans-acting enzymes and CYP2D6 metabolism in healthy individuals.

      Abstract

      The pharmacogene, CYP2D6, is commonly used to infer metabolizer phenotype of many marketed drugs and endogenous toxins in ante- and post-mortem patients but only represents the efficiency of phase 1 metabolism. Downstream metabolic enzymes encoded by UGT2B7, ABCB1, OPRM1, and COMT also have been implicated in variable individual response to drugs due to their activity at different stages of the tramadol ADME (absorption, distribution, metabolism, and excretion) process. While commonly studied as single genes using targeted genotyping approaches, a more comprehensive tramadol metabolism profile has not been evaluated. 1000 Genomes Project data for UGT2B7, ABCB1, OPRM1, and COMT were used to characterize full-gene haplotypes and their effect on protein function using in-house excel-based workbooks, PopART, and TreeView. Population genetic summary statistics and intergenic analyses associated these haplotypes with full-gene CYP2D6-inferred metabolizer phenotype. The findings suggest that UGT2B7, ABCB1, OPRM1, and COMT may contribute to predicted metabolizer phenotype as opposed to relying solely on CYP2D6.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Forensic Science International: Genetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ingelman-Sundberg M.
        • Sim S.C.
        • Gomez A.
        • Rodriguez-Antona C.
        Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
        Pharmacol. Ther. 2007; 116 (Epub 2007 Oct 9. Review. PubMed PMID: 18001838): 496-526
        • Ingelman-Sundberg M.
        Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
        Pharmacogenom. J. 2005; 5 (Review. PubMed PMID: 15492763): 6-13
        • Leathart J.B.
        • London S.J.
        • Steward A.
        • Adams J.D.
        • Idle J.R.
        • Daly A.K.
        CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.
        Pharmacogenetics. 1998; 8 (PubMed PMID: 9918137): 529-541
        • Bradford L.D.
        CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.
        Pharmacogenomics. 2002; 3 (Review. PubMed PMID: 11972444): 229-243
        • Sistonen J.
        • Fuselli S.
        • Palo J.U.
        • Chauhan N.
        • Padh H.
        • Sajantila A.
        Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales.
        Pharmacogenet. Genom. 2009; 19 (PubMed PMID: 19151603): 170-179https://doi.org/10.1097/FPC.0b013e32831ebb30
        • Gaedigk A.
        • Sangkuhl K.
        • Whirl-Carrillo M.
        • Klein T.
        • Leeder J.S.
        Prediction of CYP2D6 phenotype from genotype across world populations.
        Genet. Med. 2017; 19 (Epub 2016 Jul 7. PubMed PMID: 27388693; PubMed Central PMCID: PMC5292679): 69-76https://doi.org/10.1038/gim.2016.80
        • Levo A.
        • Koski A.
        • Ojanperä I.
        • Vuori E.
        • Sajantila A.
        Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood.
        Forensic Sci. Int. 2003; 135 (PubMed PMID: 12893130): 9-15
        • Koren G.
        • Cairns J.
        • Chitayat D.
        • Gaedigk A.
        • Leeder S.J.
        Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.
        Lancet. 2006; 368 (PubMed PMID: 16920476): 704
        • Koski A.
        • Ojanperä I.
        • Sistonen J.
        • Vuori E.
        • Sajantila A.
        A fatal doxepin poisoning associated with a defective CYP2D6 genotype.
        Am. J. Forensic Med. Pathol. 2007; 28 (PubMed PMID: 17721180): 259-261
        • Sistonen J.
        • Madadi P.
        • Ross C.J.
        • Yazdanpanah M.
        • Lee J.W.
        • Landsmeer M.L.
        • et al.
        Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.
        Clin. Pharmacol. Ther. 2012; 91 (Epub 2012 Mar 7. PubMed PMID: 22398969): 692-699https://doi.org/10.1038/clpt.2011.280
        • Smith H.S.
        Opioid metabolism.
        Mayo Clin. Proc. 2009; 84 (Review. PubMed PMID: 19567715; PubMed Central PMCID: PMC2704133): 613-624https://doi.org/10.1016/S0025-6196(11)60750-7
        • Holthe M.
        • Rakvåg T.N.
        • Klepstad P.
        • Idle J.R.
        • Kaasa S.
        • Krokan H.E.
        • et al.
        Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
        Pharmacogenom. J. 2003; 3 (Erratum in: Pharmacogenomics J. 2003;3(4):248. PubMed PMID: 12629580): 17-26
        • Campa D.
        • Gioia A.
        • Tomei A.
        • Poli P.
        • Barale R.
        Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief.
        Clin. Pharmacol. Ther. 2008; 83 (Epub 2007 Sep 26. PubMed PMID: 17898703): 559-566
        • Chung J.Y.
        • Cho J.Y.
        • Yu K.S.
        • Kim J.R.
        • Lim K.S.
        • Sohn D.R.
        • et al.
        Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects.
        Clin. Pharmacol. Ther. 2008; 83 (Epub 2007 Aug 8. PubMed PMID: 17687269): 595-600
        • Fujita K.
        • Ando Y.
        • Yamamoto W.
        • Miya T.
        • Endo H.
        • Sunakawa Y.
        • et al.
        Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.
        Cancer Chemother. Pharmacol. 2010; 65 (PubMed PMID: 19466410): 251-258https://doi.org/10.1007/s00280-009-1029-2
        • Hodges L.M.
        • Markova S.M.
        • Chinn L.W.
        • Gow J.M.
        • Kroetz D.L.
        • Klein T.E.
        • et al.
        Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).
        Pharmacogenet. Genom. 2011; 21 (PubMed PMID: 20216335; PubMed Central PMCID: PMC3098758): 152-161https://doi.org/10.1097/FPC.0b013e3283385a1c
        • Crist R.C.
        • Berrettini W.H.
        Pharmacogenetics of OPRM1.
        Pharmacol. Biochem. Behav. 2014; 123 (Epub 2013 Nov 5. Review. PubMed PMID: 24201053; PubMed Central PMCID: PMC4010567): 25-33https://doi.org/10.1016/j.pbb.2013.10.018
        • Altar C.A.
        • Carhart J.
        • Allen J.D.
        • Hall-Flavin D.
        • Winner J.
        • Dechairo B.
        Clinical utility of combinatorial pharmacogenomics-guided antidepressant therapy: evidence from three clinical studies.
        Mol. Neuropsychiatry. 2015; 1 (Epub 2015 Jul 31. PubMed PMID: 27606312; PubMed Central PMCID: PMC4996033): 145-155https://doi.org/10.1159/000430915
        • Altar C.A.
        • Carhart J.M.
        • Allen J.D.
        • Hall-Flavin D.K.
        • Dechairo B.M.
        • Winner J.G.
        Clinical validity: combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
        Pharmacogenom. J. 2015; 15 (Epub 2015 Feb 17. PubMed PMID: 25686762): 443-451https://doi.org/10.1038/tpj.2014.85
        • Bastami S.
        • Gupta A.
        • Zackrisson A.L.
        • Ahlner J.
        • Osman A.
        • Uppugunduri S.
        Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption.
        Basic Clin. Pharmacol. Toxicol. 2014; 115 (Epub 2014 May 19. PubMed PMID: 24703092): 423-431https://doi.org/10.1111/bcpt.12248
        • Handoko H.Y.
        • Nyholt D.R.
        • Hayward N.K.
        • Nertney D.A.
        • Hannah D.E.
        • Windus L.C.
        • et al.
        Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia.
        Mol. Psychiatry. 2005; 10 (PubMed PMID: 15505638): 589-597
        • Bartošová O.
        • Polanecký O.
        • Perlík F.
        • Adámek S.
        • Slanař O.
        OPRM1 and ABCB1 polymorphisms and their effect on postoperative pain relief with piritramide.
        Physiol. Res. 2015; 64 (PubMed PMID: 26681082): S521-S527
        • Christoffersen D.J.
        • Damkier P.
        • Feddersen S.
        • Möller S.
        • Thomsen J.L.
        • Brasch-Andersen C.
        • et al.
        The ABCB1, rs9282564, AG and TT genotypes and the COMT, rs4680, AA genotype are less frequent in deceased patients with opioid addiction than in living patients with opioid addiction.
        Basic Clin. Pharmacol. Toxicol. 2016; 119 (Epub 2016 May 19. PubMed PMID: 27061230): 381-388https://doi.org/10.1111/bcpt.12602
        • Sutiman N.
        • Lim J.S.
        • Muerdter T.E.
        • Singh O.
        • Cheung Y.B.
        • Ng R.C.
        • et al.
        Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and their influence on tamoxifen disposition in Asian breast cancer patients.
        Clin. Pharmacokinet. 2016; 55 (PubMed PMID: 27098059): 1239-1250https://doi.org/10.1007/s40262-016-0402-7
        • Wendt F.R.
        • Sajantila A.
        • Moura-Neto R.S.
        • Woerner A.E.
        • Budowle B.
        Full-gene haplotypes refine CYP2D6 metabolizer phenotype inferences.
        Int. J. Legal Med. 2017; ([Epub ahead of print] PubMed PMID: 29075918)https://doi.org/10.1007/s00414-017-1709-0
        • Koch W.H.
        Technology platforms for pharmacogenomic diagnostic assays.
        Nat. Rev. Drug Discov. 2004; 3 (Review. PubMed PMID: 15340385): 749-761
        • Wendt F.R.
        • Pathak G.
        • Sajantila A.
        • Chakraborty R.
        • Budowle B.
        Global genetic variation of select opiate metabolism genes in self-reported healthy individuals.
        Pharmacogenom. J. 2017; ([Epub ahead of print] PubMed PMID: 28398354))https://doi.org/10.1038/tpj.2017.13
      1. <http://www.internationalgenome.org/faq/are-1000-genomes-variant-calls-phased/>. Accessed 01FEB2017.

        • UGT Nomenclature Committee
        UGT Alleles Nomenclature Home Page.
        2005 (June, <http://www.ugtalleles.ulacal.ca/>. Accessed 20FEB2017)
        • Sai K.
        • Itoda M.
        • Saito Y.
        • Kurose K.
        • Katori N.
        • Kaniwa N.
        • et al.
        Genetic variations and haplotype structures of the ABCB1 gene in a Japanese population: an expanded haplotype block covering the distal promoter region, and associated ethnic differences.
        Ann. Hum. Genet. 2006; 70 (PubMed PMID: 16907707): 605-622
        • Sai K.
        • Kaniwa N.
        • Itoda M.
        • Saito Y.
        • Hasegawa R.
        • Komamura K.
        • et al.
        Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan.
        Pharmacogenetics. 2003; 13 (PubMed PMID: 14646693): 741-757
        • Robinson J.T.
        • Thorvaldsdóttir H.
        • Winckler W.
        • et al.
        Integrative genomics viewer.
        Nat. Biotechnol. 2011; 29 (PubMed PMID: 21221095; PubMed Central PMCID: PMC3346182): 24-26https://doi.org/10.1038/nbt.1754
        • Thorvaldsdóttir H.
        • Robinson J.T.
        • Mesirov J.P.
        Integrative Genomics Viewer (IGV): high performance genomics data visualization and exploration.
        Brief. Bioinform. 2013; 14 (Epub 2012 Apr 19. PubMed PMID: 22517427; PubMed Central PMCID: PMC3603213): 178-192https://doi.org/10.1093/bib/bbs017
        • McLaren W.
        • Gil L.
        • Hunt S.E.
        • Riat H.S.
        • Ritchie G.R.
        • Thormann A.
        • Flicek P.
        • Cunningham F.
        The ensembl variant effect predictor.
        Genome Biol. 2016; 17 (PubMed PMID: 27268795; PubMed Central PMCID: PMC4893825): 122https://doi.org/10.1186/s13059-016-0974-4
        • Kumar P.
        • Henikoff S.
        • Ng P.C.
        Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.
        Nat. Protoc. 2009; 4 (Epub 2009 Jun 25. PubMed PMID: 19561590): 1073-1081https://doi.org/10.1038/nprot.2009.86
        • Ng P.C.
        • Henikoff S.
        Predicting the effects of amino acid substitutions on protein function.
        Annu. Rev. Genom. Hum. Genet. 2006; 7 (Review. PubMed PMID: 16824020): 61-80
        • Ng P.C.
        • Henikoff S.
        SIFT: predicting amino acid changes that affect protein function.
        Nucleic Acids Res. 2003; 31 (PubMed PMID: 12824425; PubMed Central PMCID: PMC168916): 3812-3814
        • Ng P.C.
        • Henikoff S.
        Accounting for human polymorphisms predicted to affect protein function.
        Genome Res. 2002; 12 (PubMed PMID: 11875032; PubMed Central PMCID: PMC155281): 436-446
        • Ng P.C.
        • Henikoff S.
        Predicting deleterious amino acid substitutions.
        Genome Res. 2001; 11 (PubMed PMID: 11337480; PubMed Central PMCID: PMC311071): 863-874
        • Adzhubei I.A.
        • Schmidt S.
        • Peshkin L.
        • Ramensky V.E.
        • Gerasimova A.
        • Bork P.
        • Kondrashov A.S.
        • Sunyaev S.R.
        A method and server for predicting damaging missense mutations.
        Nat. Methods. 2010; 7 (PubMed PMID: 20354512; PubMed Central PMCID: PMC2855889): 248-249https://doi.org/10.1038/nmeth0410-248
        • Adzhubei I.
        • Jordan D.M.
        • Sunyaev S.R.
        Predicting functional effect of human missense mutations using PolyPhen-2.
        Curr. Protoc. Hum. Genet. 2013; (Chapter 7:Unit7.20. PubMed PMID: 23315928; PubMed Central PMCID: PMC4480630)https://doi.org/10.1002/0471142905.hg0720s76
        • Choi Y.
        • Sims G.E.
        • Murphy S.
        • Miller J.R.
        • Chan A.P.
        Predicting the functional effect of amino acid substitutions and indels.
        PLoS One. 2012; 7 (Epub 2012 Oct 8. PubMed PMID: 23056405; PubMed Central PMCID: PMC3466303): e46688https://doi.org/10.1371/journal.pone.0046688
        • Choi Y.
        • Chan A.P.
        PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels.
        Bioinformatics. 2015; 31 (Epub 2015 Apr 6. PubMed PMID: 25851949; PubMed Central PMCID: PMC4528627): 2745-2747https://doi.org/10.1093/bioinformatics/btv195
        • Choi Y.
        A fast computation of pairwise sequence alignment scores between a protein and a set of single-locus variants of another protein.
        in: Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine (BCB ‘12), ACM, New York, NY, USA2012: 414-417
        • Desmet F.O.
        • Hamroun D.
        • Lalande M.
        • Collod-Béroud G.
        • Claustres M.
        • Béroud C.
        Human Splicing Finder: an online bioinformatics tool to predict splicing signals.
        Nucleic Acids Res. 2009; 37 (PubMed PMID: 19339519; PubMed Central PMCID: PMC2685110): e67https://doi.org/10.1093/nar/gkp215
        • Weir B.S.
        Genetic Data Analysis.
        2nd ed. Sinauer Associates, Sunderland, Massachusetts1996 (376 pages)
        • Wickham H.
        ggplot2: Elegant Graphics for Data Analysis.
        Springer-Verlag, New York2009
        • Page R.D.M.
        TREEVIEW: an application to display phylogenetic trees on personal computers.
        Comput. Appl. Biosci. 1996; 12: 357-358
      2. TreeView Version 1.6.6 Build 7601. <http://taxonomy.zoology.gla.ac.uk/rod/treeview/treeview_manual.html#citing_treeview/>.

      3. Leigh, J., Bryant, D., Steel, M., Population Analysis with Reticulate Trees (PopART). <http://popart.otago.ac.nz/>.

        • Xin L.
        • Wang Z.J.
        Bioinformatic analysis of the human mu opioid receptor (OPR) splice and polymorphic variants.
        AAPS PharmSciTech. 2002; 4 (PubMed PMID: 12645995; PubMed Central PMCID: PMC2751312): E23
        • Rakvåg T.T.
        • Klepstad P.
        • Baar C.
        • Kvam T.M.
        • Dale O.
        • Kaasa S.
        • et al.
        The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
        Pain. 2005; 116 (PubMed PMID: 15927391): 73-78
        • Takigawa H.
        • Kowa H.
        • Nakashima K.
        No associations between five polymorphisms in COMT gene and migraine.
        Acta Neurol. Scand. 2017; 135 (Epub 2016 Mar 14. PubMed PMID: 26988620): 225-230https://doi.org/10.1111/ane.12583
        • Gaedigk A.
        • Simon S.D.
        • Pearce R.E.
        • Bradford L.D.
        • Kennedy M.J.
        • Leeder J.S.
        The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
        Clin. Pharmacol. Ther. 2008; 83 (Epub 2007 Oct 31. PubMed PMID: 17971818): 234-242
        • Campbell M.C.
        • Tishkoff S.A.
        African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping.
        Annu. Rev. Genom. Hum. Genet. 2008; 9 (Review. PubMed PMID: 18593304 PubMed Central PMCID: PMC2953791): 403-433https://doi.org/10.1146/annurev.genom.9.081307.164258
        • Serre D.
        • Nadon R.
        • Hudson T.J.
        Large-scale recombination rate patterns are conserved among human populations.
        Genome Res. 2005; 15 (PubMed PMID: 16251464 PubMed Central PMCID: PMC1310642): 1547-1552
        • Broman K.W.
        • Murray J.C.
        • Sheffield V.C.
        • White R.L.
        • Weber J.L.
        Comprehensive human genetic maps: individual and sex-specific variation in recombination.
        Am. J. Hum. Genet. 1998; 63 (PMID: 9718341; PMC: PMC1377399): 861-869
        • Dib C.
        • Fauré S.
        • Fizames C.
        • Samson D.
        • Drouot N.
        • Vignal A.
        • Millasseau P.
        • Marc S.
        • Hazan J.
        • Seboun E.
        • et al.
        A comprehensive genetic map of the human genome based on 5,264 microsatellites.
        Nature. 1996; 380 (PMID: 8600387): 152-154
        • Kong A.
        • Gudbjartsson D.F.
        • Sainz J.
        • Jonsdottir G.M.
        • Gudjonsson S.A.
        • Richardsson B.
        • Sigurdardottir S.
        • Barnard J.
        • Hallbeck B.
        • Masson G.
        • et al.
        A high-resolution recombination map of the human genome.
        Nat. Genet. 2002; 31 (PMID: 12053178): 241-247
        • Levran O.
        • O’Hara K.
        • Peles E.
        • Li D.
        • Barral S.
        • Ray B.
        • et al.
        ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.
        Hum. Mol. Genet. 2008; 17 (Epub 2008 Apr 17. PubMed PMID: 18424454; PubMed Central PMCID: PMC2599947): 2219-2227https://doi.org/10.1093/hmg/ddn122
        • Fuselli S.
        • de Filippo C.
        • Mona S.
        • Sistonen J.
        • Fariselli P.
        • Destro-Bisol G.
        • et al.
        Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus.
        Pharmacogenet. Genom. 2010; 20 (PubMed PMID: 20520586): 485-499https://doi.org/10.1097/FPC.0b013e32833bba25
        • Hung C.C.
        • Chiou M.H.
        • Teng Y.N.
        • Hsieh Y.W.
        • Huang C.L.
        • Lane H.Y.
        Functional impact of ABC variants on interactions between P-glycoprotein and methadone.
        PLoS One. 2013; 8: e59419https://doi.org/10.1371/journal.pone.0059419
        • Yuferov V.
        • Levran O.
        • Proudnikov D.
        • Nielsen D.A.
        • Kreek M.J.
        Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.
        Ann. N. Y. Acad. Sci. 2010; 1187 (Review. PubMed PMID: 20201854; PubMed Central PMCID: PMC3769182): 184-207https://doi.org/10.1111/j.1749-6632.2009.05275.x
        • Kim M.K.
        • Moore J.H.
        • Kim J.K.
        • Cho K.H.
        • Cho Y.W.
        • Kim Y.S.
        • Lee M.C.
        • Kim Y.O.
        • Shin M.H.
        Evidence for epistatic interactions in antiepileptic drug resistance.
        J. Hum. Genet. 2011; 56 (Epub 2010 Dec 2. PubMed PMID: 21124337): 71-76https://doi.org/10.1038/jhg.2010.151
        • McCarroll S.A.
        • Hadnott T.N.
        • Perry G.H.
        • Sabeti P.C.
        • Zody M.C.
        • Barrett J.C.
        • Dallaire S.
        • Gabriel S.B.
        • Lee C.
        • Daly M.J.
        • Altshuler D.M.
        • International HapMap Consortium
        Common deletion polymorphisms in the human genome.
        Nat. Genet. 2006; 38 (PubMed PMID: 16468122): 86-92
        • Drögemöller B.I.
        • Wright G.E.
        • Niehaus D.J.
        • Emsley R.
        • Warnich L.
        Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment.
        Pharmacogenet. Genom. 2013; 23 (PubMed PMID: 24141736): 666-674https://doi.org/10.1097/FPC.0000000000000006
        • Wright G.E.
        • Carleton B.
        • Hayden M.R.
        • Ross C.J.
        The global spectrum of protein-coding pharmacogenomic diversity.
        Pharmacogenom. J. 2016; ([Epub ahead of print] PubMed PMID: 27779249)https://doi.org/10.1038/tpj.2016.77
        • Deamer D.W.
        • Akeson M.
        Nanopores and nucleic acids: prospects for ultrarapid sequencing.
        Trends Biotechnol. 2000; 18 (Review. PubMed PMID: 10740260): 147-151
        • Kasianowicz J.J.
        • Brandin E.
        • Branton D.
        • Deamer D.W.
        Characterization of individual polynucleotide molecules using a membrane channel.
        Proc. Natl. Acad. Sci. U. S. A. 1996; 93 (PubMed PMID: 8943010; PubMed Central PMCID: PMC19421): 13770-13773
        • Ammar R.
        • Paton T.A.
        • Torti D.
        • Shlien A.
        • Bader G.D.
        Long read nanopore sequencing for detection of HLA and CYP2D6 variants and haplotypes.
        F1000Research. 2015; 4 (eCollection 2015. PubMed PMID: 25901276; PubMed Central PMCID: PMC4392832): 17https://doi.org/10.12688/f1000research.6037.1
        • Lindberg M.R.
        • Schmedes S.E.
        • Hewitt F.C.
        • Haas J.L.
        • Ternus K.L.
        • Kadavy D.R.
        • Budowle B.
        A comparison and integration of MiSeq and MinION platforms for sequencing single source and mixed mitochondrial genomes.
        PLoS One. 2016; 11 (eCollection 2016. PubMed PMID: 27936026; PubMed Central PMCID: PMC5147911): e0167600https://doi.org/10.1371/journal.pone.0167600
        • Dong C.
        • Wei P.
        • Jian X.
        • Gibbs R.
        • Boerwinkle E.
        • Wang K.
        • Liu X.
        Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.
        Hum. Mol. Genet. 2015; 24 (Epub 2014 Dec 30. PubMed PMID: 25552646; PubMed Central PMCID: PMC4375422): 2125-2137https://doi.org/10.1093/hmg/ddu733
        • Fallin D.
        • Cohen A.
        • Essioux L.
        • Chumakov I.
        • Blumenfeld M.
        • Cohen D.
        • et al.
        Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer’s disease.
        Genome Res. 2001; 11 (PubMed PMID: 11156623; PubMed Central PMCID: PMC311030): 143-151
        • Luo X.
        • Zuo L.
        • Kranzler H.
        • Zhang H.
        • Wang S.
        • Gelernter J.
        Multiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populations.
        Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008; 147B (PubMed PMID: 18213616; PubMed Central PMCID: PMC3162230): 1028-1039https://doi.org/10.1002/ajmg.b.30701
        • Mattei J.
        • Parnell L.D.
        • Lai C.Q.
        • Garcia-Bailo B.
        • Adiconis X.
        • Shen J.
        • et al.
        Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites.
        BMC Genet. 2009; 10 (PubMed PMID: 19682384; PubMed Central PMCID: PMC2734553): 45https://doi.org/10.1186/1471-2156-10-45
        • Yang Y.
        • Botton M.R.
        • Scott E.R.
        • Scott S.A.
        Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.
        Pharmacogenomics. 2017; 18 (Epub 2017 May 4. PubMed PMID: 28470112): 673-685https://doi.org/10.2217/pgs-2017-0033